Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects-Reference-Cited by-同舟云学术

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects

Published:2008-06 Issue:6 Volume:65 Page:848-854
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kim Bo-Hyung,Lim Hyeong-Seok,Chung Jae-Yong,Kim Jung-Ryul,Lim Kyoung Soo,Sohn Dong-Ryul,Cho Joo-Youn,Yu Kyung-Sang,Shin Sang-Goo,Paick Jae-Seung,Jang In-Jin

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2008.03107.x/fullpdf

Reference20 articles.

1. Predictors and Prevalence of Erectile Dysfunction in a Racially Diverse Population

2. Erectile Dysfunction

3. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

4. Sildenafil for Male Erectile Dysfunction

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11

2. Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments;Expert Opinion on Investigational Drugs;2023-07-03

3. Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers;Clinical Pharmacology in Drug Development;2022-05

4. The Effect of Udenafil on Stasis Zone in an Experimental Burn Model;Annals of Plastic Surgery;2022-01

5. A Comprehensive Approach in the Treatment of Erectile Dysfunction in Obesity Patients;Health of Man;2021-12-30